Susan D'Costa, Ph.D.

Chief Technology Officer and Commercial Officer at Genezen, USA

Speaker

Susan D’Costa is a molecular virologist spanning 25 years of experience in virology. Over the past ten years, she has been actively involved in viral vector analytics, process development, manufacturing, and building successful teams. She is currently the Chief Technical and Commercial Officer at Genezen, a leading gene and cell therapy CDMO. Prior to Genezen, Susan was CTO at Alcyone Therapeutics, a biotechnology company pioneering next-generation CNS precision gene-based therapeutics for complex neurological conditions. At Alcyone, she was responsible for viral vector CMC, device development operations and partnering on new technologies for both gene therapy and precision delivery. Dr. D’Costa has also held leadership roles of increasing responsibility at Thermo Fisher Scientific, Viral Vector Services, and its predecessor companies – Brammer Bio and Florida Biologix, working with different viral vectors, liaising with diverse biotech clients, and building teams with scientific and operational excellence. Susan holds a PhD in biology, specializing in molecular virology, from Texas Tech University; an MS in biochemistry from Mumbai University (Grant Medical College), and a BS in microbiology/biochemistry also from Mumbai University (St. Xavier’s College).